HRP20040900B1 - Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> - Google Patents
Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub>Info
- Publication number
- HRP20040900B1 HRP20040900B1 HR20040900A HRP20040900A HRP20040900B1 HR P20040900 B1 HRP20040900 B1 HR P20040900B1 HR 20040900 A HR20040900 A HR 20040900A HR P20040900 A HRP20040900 A HR P20040900A HR P20040900 B1 HRP20040900 B1 HR P20040900B1
- Authority
- HR
- Croatia
- Prior art keywords
- sub
- cyclopropylglycinyl
- piperidin
- inhibitors
- certain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36852302P | 2002-04-01 | 2002-04-01 | |
| PCT/US2003/007794 WO2003084929A1 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20040900A2 HRP20040900A2 (en) | 2004-12-31 |
| HRP20040900B1 true HRP20040900B1 (en) | 2006-02-28 |
Family
ID=28791889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20040900A HRP20040900B1 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7166606B2 (enExample) |
| EP (1) | EP1492767B1 (enExample) |
| JP (1) | JP2005531529A (enExample) |
| KR (1) | KR20040094892A (enExample) |
| CN (1) | CN1288135C (enExample) |
| AT (1) | ATE303990T1 (enExample) |
| AU (1) | AU2003218147A1 (enExample) |
| BR (1) | BR0308870A (enExample) |
| CA (1) | CA2478340A1 (enExample) |
| CR (1) | CR7497A (enExample) |
| DE (1) | DE60301569T2 (enExample) |
| DK (1) | DK1492767T3 (enExample) |
| EA (1) | EA007300B1 (enExample) |
| EC (1) | ECSP045329A (enExample) |
| ES (1) | ES2248737T3 (enExample) |
| HR (1) | HRP20040900B1 (enExample) |
| IL (1) | IL164018A0 (enExample) |
| MX (1) | MXPA04009640A (enExample) |
| NO (1) | NO20044688L (enExample) |
| NZ (1) | NZ535402A (enExample) |
| PL (1) | PL373066A1 (enExample) |
| UA (1) | UA76849C2 (enExample) |
| WO (1) | WO2003084929A1 (enExample) |
| ZA (1) | ZA200407418B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6834308B1 (en) | 2000-02-17 | 2004-12-21 | Audible Magic Corporation | Method and apparatus for identifying media content presented on a media playing device |
| US7363278B2 (en) | 2001-04-05 | 2008-04-22 | Audible Magic Corporation | Copyright detection and protection system and method |
| US8972481B2 (en) | 2001-07-20 | 2015-03-03 | Audible Magic, Inc. | Playlist generation method and apparatus |
| DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
| WO2018093716A1 (en) * | 2016-11-18 | 2018-05-24 | Merck Sharp & Dohme Corp. | FACTOR XIIa INHIBITORS |
| EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000077027A2 (en) | 1999-06-14 | 2000-12-21 | Tularik Limited | Serine protease inhibitors |
| WO1999011657A1 (en) | 1997-08-29 | 1999-03-11 | Proteus Molecular Design Ltd. | 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| JP2003502314A (ja) | 1999-06-14 | 2003-01-21 | イーライ・リリー・アンド・カンパニー | 化合物 |
| GB0030305D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030303D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030306D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| TWI257389B (en) | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
| DE60224805T2 (de) * | 2001-07-26 | 2009-01-22 | Eli Lilly And Co., Indianapolis | 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine und -piperidine als faktor-xa-antagonisten |
-
2003
- 2003-03-24 AU AU2003218147A patent/AU2003218147A1/en not_active Abandoned
- 2003-03-24 DK DK03714138T patent/DK1492767T3/da active
- 2003-03-24 UA UA20041008649A patent/UA76849C2/uk unknown
- 2003-03-24 IL IL16401803A patent/IL164018A0/xx unknown
- 2003-03-24 PL PL03373066A patent/PL373066A1/xx unknown
- 2003-03-24 WO PCT/US2003/007794 patent/WO2003084929A1/en not_active Ceased
- 2003-03-24 CN CNB038074141A patent/CN1288135C/zh not_active Expired - Fee Related
- 2003-03-24 JP JP2003582128A patent/JP2005531529A/ja active Pending
- 2003-03-24 DE DE60301569T patent/DE60301569T2/de not_active Expired - Fee Related
- 2003-03-24 KR KR10-2004-7015486A patent/KR20040094892A/ko not_active Ceased
- 2003-03-24 AT AT03714138T patent/ATE303990T1/de not_active IP Right Cessation
- 2003-03-24 CA CA002478340A patent/CA2478340A1/en not_active Abandoned
- 2003-03-24 MX MXPA04009640A patent/MXPA04009640A/es active IP Right Grant
- 2003-03-24 US US10/486,138 patent/US7166606B2/en not_active Expired - Fee Related
- 2003-03-24 ES ES03714138T patent/ES2248737T3/es not_active Expired - Lifetime
- 2003-03-24 EA EA200401290A patent/EA007300B1/ru not_active IP Right Cessation
- 2003-03-24 BR BR0308870-7A patent/BR0308870A/pt not_active IP Right Cessation
- 2003-03-24 HR HR20040900A patent/HRP20040900B1/xx not_active IP Right Cessation
- 2003-03-24 NZ NZ535402A patent/NZ535402A/en unknown
- 2003-03-24 EP EP03714138A patent/EP1492767B1/en not_active Expired - Lifetime
-
2004
- 2004-09-15 ZA ZA200407418A patent/ZA200407418B/en unknown
- 2004-09-24 CR CR7497A patent/CR7497A/es unknown
- 2004-09-29 EC EC2004005329A patent/ECSP045329A/es unknown
- 2004-10-29 NO NO20044688A patent/NO20044688L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20050096328A1 (en) | 2005-05-05 |
| NO20044688L (no) | 2004-10-29 |
| BR0308870A (pt) | 2005-01-04 |
| WO2003084929A1 (en) | 2003-10-16 |
| ZA200407418B (en) | 2005-09-15 |
| US7166606B2 (en) | 2007-01-23 |
| MXPA04009640A (es) | 2005-01-11 |
| EA200401290A1 (ru) | 2005-02-24 |
| PL373066A1 (en) | 2005-08-08 |
| CR7497A (es) | 2005-01-17 |
| ES2248737T3 (es) | 2006-03-16 |
| HK1070363A1 (en) | 2005-06-17 |
| WO2003084929A8 (en) | 2004-05-21 |
| CN1642914A (zh) | 2005-07-20 |
| DK1492767T3 (da) | 2005-11-28 |
| EP1492767A1 (en) | 2005-01-05 |
| IL164018A0 (en) | 2005-12-18 |
| HRP20040900A2 (en) | 2004-12-31 |
| KR20040094892A (ko) | 2004-11-10 |
| DE60301569D1 (de) | 2005-10-13 |
| UA76849C2 (uk) | 2006-09-15 |
| EA007300B1 (ru) | 2006-08-25 |
| ATE303990T1 (de) | 2005-09-15 |
| ECSP045329A (es) | 2004-11-26 |
| NZ535402A (en) | 2006-02-24 |
| EP1492767B1 (en) | 2005-09-07 |
| AU2003218147A1 (en) | 2003-10-20 |
| DE60301569T2 (de) | 2006-06-14 |
| CN1288135C (zh) | 2006-12-06 |
| JP2005531529A (ja) | 2005-10-20 |
| CA2478340A1 (en) | 2003-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1585739T3 (da) | Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer | |
| SE0100902D0 (sv) | Compounds | |
| NO20041493L (no) | Kjemiske forbindelser. | |
| NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
| TW200602322A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| ATE403429T1 (de) | Spiropyrazol-verbindungen | |
| HRP20080226T3 (en) | Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors | |
| ATE383338T1 (de) | N-(phenyl(piperidin-2-yl)methyl)benzamid-deriva e,verfahren zu deren herstellung und ihre therapeutische verwendung | |
| SE0100903D0 (sv) | Compounds | |
| SE0004245D0 (sv) | Novel compounds and their use | |
| WO2004031145A3 (en) | Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors | |
| SE0103710D0 (sv) | Compounds | |
| BG107003A (en) | Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases | |
| HRP20040900B1 (en) | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> | |
| DE60202669D1 (de) | 6-phenylbenzonaphthyidine | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| NO20050871L (no) | 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer | |
| NO20023951L (no) | Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler | |
| ATE372982T1 (de) | 2-(3-sulfonylamino-2-oxopyrrolidin-1- yl)propanamide als factor xa inhibitoren | |
| DE602004009306D1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern | |
| NO20050764L (no) | Forbindelser | |
| EP1632228A4 (en) | MEDICINAL COMPOSITION CONTAINING TRIAZOLE COMPOUND | |
| ATE349427T1 (de) | Tryptaseinhibitoren | |
| DK1392652T3 (da) | Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner | |
| SI1492767T1 (sl) | Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20080304 Year of fee payment: 6 |
|
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20090325 |